Kieran English is a member of Spencer Stuart’s Healthcare Practice. She focuses on senior executive and board director searches within the biotechnology and medical technology markets, with a particular focus on precision medicine. Her clients have ranged from Fortune 500 companies to venture-backed enterprises. Kieran partners with the boards and investors of these organizations to advise them on leadership and talent acquisition issues. She has spent a significant amount of time in the San Francisco, San Diego and Boston markets. As a former executive in the industry, Kieran brings firsthand understanding of the challenges and opportunities facing healthcare leaders.
Healthcare search and leadership expertise
- Prior to joining Spencer Stuart, Kieran was a partner with another leading global executive search firm, where she led the creation of the precision medicine practice. Kieran was also instrumental in building the firm’s presence in the Texas healthcare market.
- Previously, Kieran was director of business development at Geron Corporation, where she was responsible for licensing deals, corporate partnerships, acquisitions and asset management.
- Kieran also held numerous roles with Novartis/Chiron, most recently as associate director of business development for vaccines and diagnostics. During her tenure, she focused on mergers and acquisitions activity in the oncology and infectious disease areas, licensing deals in the blood safety space and strategic opportunities in the molecular diagnostic industry. Kieran also lived in Paris and was responsible for Chiron’s geographic expansion of blood testing products into the emerging markets. Earlier in her career, she spent a number of years as an analyst with a biotechnology-focused hedge fund.
Kieran received her B.A. in English literature from Manhattan College and her M.B.A. in finance from Fordham University. She is an active a member of the Personalized Medicine Coalition and the American Red Cross Tiffany Circle.